Home / Mumbai / Mumbai News / Article /
Families lose lakhs on unapproved autism treatments, SC issues strict guidelines
Updated On: 02 April, 2026 08:46 AM IST | Mumbai | Ritika Gondhalekar
The Supreme Court of India has warned against unapproved stem cell therapy for autism, allowing it only in approved clinical trials, and urged action against misleading claims, while experts recommend supportive therapies as effective alternatives

Dr Rashmi Yeradkar, Occupational Therapy Department, Sion Hospital. Pic/Ritika Gondhalekar
Ahead of World Autism Awareness Day on April 2, the Supreme Court of India has issued strict guidelines cautioning against the use of stem cell therapy for autism. Authorities have been directed to act against misleading advertisements and unproven treatments. The move follows concerns raised by advocacy groups that families have spent over Rs 10 lakh on such therapies without scientific backing or positive outcomes.
“Many families faced severe financial strain chasing these treatments and got nothing in return,” said Parul Kumtha, trustee and co-founder, Forum for Autism, and one of the petitioners in the Public Interest Litigation (PIL) filed at the SC.

